N.Y. Bill: Ban Equine Performance-Enhancing Drugs

N.Y. Bill: Ban Equine Performance-Enhancing Drugs

A memo attached to the bill says its purpose is to "prohibit the use of any performance-enhancing drug ... on horses that participate in horse racing in the state of New York."

Photo: Anne M. Eberhardt/The Horse

Legislation calling for a ban on equine performance-enhancing drugs in horse racing has been sent to the New York Senate Racing, Gaming, and Wagering Committee.

The language in the measure is similar to that of federal legislation that has been floated but not acted upon the past several years. The bill doesn't specifically mention the anti-bleeding medication furosemide, also known as Salix or Lasix, but a memo attached to the bill says its purpose is to "prohibit the use of any performance-enhancing drug, including Lasix, on horses that participate in horse racing in the state of New York."

The bill was introduced Jan. 9 by Democratic Sen. Adriano Espaillat; the Senate is controlled by Republicans. Also, there currently are no co-sponsors and no companion bill in the Assembly. The bill did not stem from the administration of Democratic Gov. Andrew Cuomo.

The legislation states a performance-enhancing drug is "any substance capable of affecting the performance of a horse at any time by acting on the nervous system, cardiovascular system, respiratory system, digestive system, urinary system, reproductive system, musculoskeletal system, blood system, immune system (other than licensed vaccines against infectious agents), or endocrine system of the horse."

It calls for a minimum 180-day suspension upon the first violation, a minimum one-year suspension for a second violation, and "permanent banishment from all activities related to horse racing" for a third violation.

The New York State Racing and Wagering Board, which is about to be folded into a broader Gaming Commission, began taking comments on the use of Salix last year but hasn't acted upon a regulation. Horsemen's groups support a ban on performance-enhancing drugs but strongly oppose a ban on race-day use of Salix.

Tom Precious contributed to this story

Originally published on BloodHorse.com.

About the Author

Tom LaMarra

Tom LaMarra, a native of New Jersey and graduate of Rutgers University, has been news editor at The Blood-Horse since 1998. After graduation he worked at newspapers in New Jersey and Pennsylvania as an editor and reporter with a focus on municipal government and politics. He also worked at Daily Racing Form and Thoroughbred Times before joining The Blood-Horse. LaMarra, who has lived in Lexington since 1994, has won various writing awards and was recognized with the Old Hilltop Award for outstanding coverage of the horse racing industry. He likes to spend some of his spare time handicapping races.

Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners